美股异动 | 传至少与一家大型制药商进行收购谈判 Moderna(MRNA.US)涨超9%

Core Viewpoint - Moderna's stock price increased by over 9%, reaching $26.95, following news of potential acquisition discussions with at least one major pharmaceutical company [1] Group 1 - Moderna is reportedly in acquisition talks with a large pharmaceutical company, indicating potential strategic growth opportunities [1] - The stock price surge reflects market optimism regarding the outcome of these discussions [1]